ProductLife Group

ProductLife Group is one of the three global specialists in the regulatory affairs and pharmacovigilance market on behalf of major pharmaceutical companies. The group offers its clients global coverage through its offices in over 100 countries.

ProductLife Group

“Become the global reference player in regulatory affairs & pharmacovigilance for pharmaceutical laboratories”

ProductLife Group, based in Paris, was founded in 1993. The group operates at the crossroads of Healthcare and Business services providing regulatory affairs and pharmacovigilance management for pharmaceutical laboratories. Its day-to-day business consists in putting drugs or medical devices onto the market, maintaining them throughout their life cycle and then monitoring side effects . Supported by 21 Invest in France, ProductLife Group has structured its organization and now optimizes its organic growth and accelerates its buy-and-build strategy in France and internationally.

21 Invest France invested in ProductLife Group in 2019, in the frame of a primary transaction, with the objective to assert the leadership of the group and intensify its international coverage to serve more and more Life Science corporations in their worldwide operations.

Right from the investment date, ProductLife Group has undertaken a deep transformation plan which required to rethink the organization and make it ready for the ambitious international development. Regarding the structuring aspects, 21 Invest recruited Xavier Duburcq as new CEO and together we implemented all the necessary tools to monitor financial and commercial performance. We also created an M&A Department and implemented the right financial structure to support the group’s growth.

Over the first years of the investment, 21 Invest initiated the platform strategy roll-out with the completion of multiple acquisitions enabling ProductLife Group to tackle new segments such as pre-marketing of consulting services, and/or to intensify its geographical footprint in the US, Central Europe or Asia. Many other opportunities have been identified to reach a critical size by the end of 21 Invest’s tenure.

Supported by 21 Invest, they notably set up dedicated ESG KPIs and they became signatory of the UN Global Compact initiative. The investment was the first investment of its generation of Funds to transform its financial debt into an ESG debt, including objectives in the areas of parity, young talents recruitment or employee share scheme.

Key figures
7 of the top 10

pharmaceutical companies turn to ProductLife Group

    €M 47,2

    sales in 2021


      Countries covered


        Experts worldwide

          “ProductLife Group is ideally positioned in a booming market. We are delighted to accompany the team in the realization of its project combining resilience, strong growth and acquisition opportunities allowing ProductLife to reveal its full potential and become an undisputed leader on its market.”

          Fabrice Voituron, Managing Partner chez 21 Invest France

          Geometric Shape
          Geometric Shape
          Geometric Shape
          Geometric Shape
          Geometric Shape
          Geometric Shape